![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 12
2024
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; Visco, Carlo; Meerten, Tom van; Wirths, Stefan; Zinzani, Pier Luigi; Novak, Urban; Herhaus, Peter; Benedetti, Fabio; Sonnevi, Kristina; Hanoun, Christine; Hänel, Matthias; Dierlamm, Judith; Pott, Christiane; Klapper, Wolfram; Gözel, Döndü; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco und Hoster, Eva 
ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 403, Nr. 10441: S. 2293-2306
ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 403, Nr. 10441: S. 2293-2306
2023
Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
2022
Tilch, Marie-Kristin; Visco, Carlo; Kinda, Sandra; Hermine, Olivier; Kohn, Milena; Besson, Caroline; Lamure, Sylvain; Dulery, Remy; Ragaini, Simone; Eyre, Toby A.; Meerten, Tom van; Ohler, Anke; Eckerle, Steffen; Dreyling, Martin; Hess, Georg; Gine, Eva und da Silva, Maria Gomes
(2022):
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry.
In: Hemasphere, Bd. 6, Nr. 5, e0711
Hess, Georg; Huettmann, Andreas; Witzens-Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias und Lenz, Georg
(2022):
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
In: British Journal of Haematology, Bd. 198, Nr. 3: S. 482-491
2021
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meissner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosee, Paul; Buske, Christian; Dreyling, Martin H. und Hess, Georg
(2021):
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
In: Hemasphere, Bd. 5, Nr. 10, e636
2020
Hess, Georg; Wagner, Karola; Keller, Ulrich; La Rosee, Paul; Atta, Johannes; Hübel, Kai; Lerchenmueller, Christian; Schoendube, Daniel; Witzens-Harig, Mathias; Ruckes, Christian; Medler, Christoph; Oordt, Christina van; Klapper, Wolfram; Theobald, Matthias und Dreyling, Martin
(2020):
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.
In: Hemasphere, Bd. 4, Nr. 3, e398
2019
Knop, Stefan; Engelhardt, Monika; Liebisch, Peter; Meisner, Christoph; Holler, Ernst; Metzner, Bernd; Peest, Dietrich; Kaufmann, Martin; Bunjes, Donald; Straka, Christian; Fischer, Thomas; Sezer, Orhan; Hentrich, Marcus; Ostermann, Helmut; Bassermann, Florian; Hess, Georg; Hertenstein, Bernd; Freund, Mathias; Kropff, Martin; Schmidt, Christian A.; Wolf, Hans-Heinrich; Jung, Wolfram; Frickhofen, Norbert; Mielke, Stephan; Bargou, Ralf C.; Maschmeyer, Georg; Svaldi, Mirija; Langer, Christian H.; Gramatzki, Martin; Hebart, Holger; Kanz, Lothar; Einsele, Hermann; Sezer, O.; Doerken, B.; Gerecke, C.; Fuhrmann, S.; Ludwig, W. D.; Hertenstein, B.; Bormann, M.; Meyer, R.; Naumann, R.; Platzbecker, U.; Roellig, Ch; Roesler, W.; Metzler, I. von; Martin, H.; Engelhardt, M.; Finke, J.; Truemper, L.; Jung, W.; Schmidt, Ch A.; Doelken, G.; Wolf, H. H.; Müller, L.; Ligeti, K.; Kröger, N.; Schilling, G.; Duerk, H.; Peest, D.; Ganser, A.; Pfreundschuh, M.; Sayer, H.; Lilienfeld-Toal, M. von; Muegge, L. O.; Bentz, M.; Gramatzki, M.; Brueggemann, M.; Fischer, T.; Wolleschak, D.; Hess, G.; Kropff, M.; Reusch, J.; Straka, C.; Ostermann, H.; Franke, D.; Peschel, C.; Dechow, T.; Bassermann, F.; Hentrich, M.; Wandt, H.; Schäfer-Eckart, K.; Metzner, B.; Maschmeyer, G.; Holler, E.; Hart, C.; Reichle, A.; Freund, M.; Böttcher, S.; Kahl, C.; Mergenthaler, H. G.; Aulitzky, W.; Kaufmann, M.; Greiner, J.; Heidemann, E.; Kanz, L.; Hebart, H.; Liebisch, P.; Bunjes, D.; Langer, C.; Frickhofen, N.; Einsele, H.; Knop, S.; Mielke, S.; Bargou, R. C. und Svaldi, M.
(2019):
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
In: Leukemia, Bd. 33, Nr. 11: S. 2710-2719
2018
Dreyling, Martin; Aurer, Igor; Cortelazzo, Sergio; Hermine, Olivier; Hess, Georg; Jerkeman, Mats; Le Gouill, Steven; Ribrag, Vincent; Trneny, Marek; Visco, Carlo; Walewski, Jan; Zaja, Francesco und Zinzani, Pier Luigi
(2018):
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.
In: Leukemia & Lymphoma, Bd. 59, Nr. 8: S. 1814-1828
2017
Rule, Simon; Dreyling, Martin; Goy, Andre; Hess, Georg; Auer, Rebecca; Kahl, Brad; Cavazos, Nora; Liu, Black; Yang, Shiyi; Clow, Fong; Goldberg, Jenna D.; Beaupre, Darrin; Vermeulen, Jessica; Wildgust, Mark und Wang, Michael
(2017):
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
In: British Journal of Haematology, Bd. 179, Nr. 3: S. 430-438
Hess, Georg; Rule, Simon; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Zhou, Wenjiong; Goldberg, Jenna D.; Trambitas, Cristina; Enny, Christopher; Vermeulen, Jessica; Traina, Shana; Chiou, Chiun-Fang; Diels, Joris und Dreyling, Martin
(2017):
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.
In: Leukemia & Lymphoma, Bd. 58, Nr. 12: S. 2824-2832
2016
Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Santucci Silva, Rodrigo; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Balasubramanian, Sriram; Bandyopadhyay, Nibedita; Sun, Steven; Vermeulen, Jessica; Rizo, Aleksandra und Rule, Simon
(2016):
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study.
In: Lancet, Bd. 387, Nr. 10020: S. 770-778
2013
Witzens-Harig, Mathias; Memmer, Marie Luise; Dreyling, Martin und Hess, Georg
(2013):
A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma - the STORM trial.
In: BMC Cancer
13:308
[PDF, 223kB]